WeVote
Log In

Bill

Bill

HB 5492

PRESCRIPTION HORMONE THERAPY

104th Regular Session Introduced by Jaime Andrade and 27 co-sponsors

Illinois bill HB 5492 addresses prescription hormone therapy access and requirements, currently in Rules Committee referral stage with multiple sponsors.

Sent to the Governor
0
WeVote Research Nonpartisan
Bill Summary · HB 5492

Legislative bill overview

HB 5492 appears to be legislation addressing prescription hormone therapy, though the specific provisions are not detailed in the available information. Based on the bill title and sponsor list, it likely pertains to access, coverage, regulation, or clinical standards for hormone-related medications in Illinois. The bill is currently in early legislative stages, having just received its first reading and been referred to the Rules Committee.

Why is this important

Prescription hormone therapy legislation can affect significant populations—including transgender individuals, people undergoing fertility treatments, and those managing menopause or hormone-related conditions. Such bills determine insurance coverage requirements, age restrictions, informed consent procedures, and clinical oversight, directly impacting healthcare access and costs for Illinois residents.

Potential points of contention

  • Scope of coverage: Whether private insurance and/or Medicaid must cover hormone therapies, and under what circumstances
  • Age-related provisions: Minimum age requirements for different types of hormone therapy and parental consent/notification rules
  • Clinical standards: Who can prescribe, what protocols must be followed, and whether certain evaluations are mandatory
  • Definitions and inclusivity: How broadly or narrowly "hormone therapy" is defined and which treatments are included or excluded

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.